Skip to content
Recall Observatory FDA recall evidence

Drug product

Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI NDC 0904-6509-04

D-0692-2017

December 27, 2016

Class III

Product summary

Firm
The Harvard Drug Group
Event
Event 77105
Status
Terminated
Classification
Class III
Quantity
36,990 tablets
Official record key
drug-enforcement:D-0692-2017

Official wording

Reason: Superpotent Drug; out of specification results for assay (manufacturer)

Code information: LOT: T-00601 Exp: 04-2017

Distribution pattern: Nationwide and PR

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Superpotent